Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US

$500 Savings End In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 13 - 16, 2026
Marriott Marquis San Diego

Meghan Verstraete, PhD
Senior Scientist, Protein Engineering at Zymeworks
Speaker

Profile

Meghan Verstraete, PhD, is a Senior Scientist at Zymeworks specializing in protein engineering and multispecific antibody therapeutics. She has extensive experience applying structure-guided and data-driven approaches to antibody design, optimization, and developability. Her work spans molecular architecture selection, paratope optimization, and cross-functional leadership of preclinical therapeutic programs in immuno-oncology and autoimmune disease. Meghan holds a PhD from the University of British Columbia.

Agenda Sessions

  • Engineering Trispecific T Cell Engagers (TriTCEs) For Optimal Activity and Developability

    , 8:45am